Gl
Non verificato

Glaukos Corporation

Di cosa scriviamo

Attrezzature medico-sanitarieFarmaceuticaOtticaSaluteWeb e Social Network
03/11/2026
Eventi
Biotecnologia
Farmaceutica
Ottica
Salute
Glaukos Announces Participation in Upcoming Investor Conferences
1.00
28/10/2026
Salute
Comunicazione
Attrezzature medico-sanitarie
Sanità
Farmaceutica
Web e Social Network
Telefonia e Varie
Mercato azionario
Glaukos Announces Third Quarter 2026 Financial Results
1.00
08/10/2026
Mercato del lavoro
Industria
Attrezzature medico-sanitarie
Salute
Farmaceutica
Ottica
Biotecnologia
Glaukos Announces Exclusive License Agreement with RevOpsis Therapeutics to Develop and Commercialize RO-104, a First-in-Class Tri-Specific Biologic for Retinal Diseases
1.00
07/10/2026
Industria
Biotecnologia
Salute
Farmaceutica
Ottica
Medicina - Varie
Glaukos Announces Positive Three-Year Epioxa® Results Demonstrating Durable Clinical Outcomes in Keratoconus
1.00
07/10/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Attrezzature medico-sanitarie
Salute
Medicina - Varie
Farmaceutica
Ottica
Glaukos to Release Third Quarter 2026 Financial Results after Market Close on October 28
1.00
23/09/2026
Industria
Pallacanestro
Attrezzature medico-sanitarie
Sport
Biotecnologia
Sanità
Farmaceutica
Salute
Ottica
Glaukos Partners with NBA Champion Stephen Curry to Launch “Could it be KC?” Campaign to Raise Awareness of Keratoconus
1.00
19/08/2026
Eventi
Web e Social Network
Biotecnologia
Attrezzature medico-sanitarie
Salute
Farmaceutica
Ottica
Glaukos Announces Participation in Wells Fargo Healthcare Conference
1.00
29/07/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Attrezzature medico-sanitarie
Salute
Farmaceutica
Ottica
Biotecnologia
Glaukos Announces Second Quarter 2026 Financial Results
1.00
27/07/2026
Industria
Medicina - Varie
Attrezzature medico-sanitarie
Salute
Ottica
Glaukos Announces Completion of Patient Enrollment in 510(k) Pivotal Study for PRESERFLO™ MicroShunt
1.00

Recapiti

Social Media

Seguaci
0
Compatibilità
0